ArticleOncoimmunology2021

Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancer.

Cong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.